Eupraxia Pharmaceuticals Pink Sheet Forecast - 20 Period Moving Average
| EPRX Stock | 3.37 0.23 6.39% |
Eupraxia |
Eupraxia Pharmaceuticals 20 Period Moving Average Price Forecast For the 23rd of November
Given 90 days horizon, the 20 Period Moving Average forecasted value of Eupraxia Pharmaceuticals Common on the next trading day is expected to be 3.04 with a mean absolute deviation of 0.24, mean absolute percentage error of 0.12, and the sum of the absolute errors of 9.81.Please note that although there have been many attempts to predict Eupraxia Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eupraxia Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eupraxia Pharmaceuticals Pink Sheet Forecast Pattern
Eupraxia Pharmaceuticals Forecasted Value
In the context of forecasting Eupraxia Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eupraxia Pharmaceuticals' downside and upside margins for the forecasting period are 0.03 and 8.16, respectively. We have considered Eupraxia Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Eupraxia Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Eupraxia Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 79.1913 |
| Bias | Arithmetic mean of the errors | -0.1287 |
| MAD | Mean absolute deviation | 0.2394 |
| MAPE | Mean absolute percentage error | 0.0805 |
| SAE | Sum of the absolute errors | 9.815 |
Predictive Modules for Eupraxia Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eupraxia Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Eupraxia Pharmaceuticals
For every potential investor in Eupraxia, whether a beginner or expert, Eupraxia Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eupraxia Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eupraxia. Basic forecasting techniques help filter out the noise by identifying Eupraxia Pharmaceuticals' price trends.Eupraxia Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eupraxia Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eupraxia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eupraxia Pharmaceuticals Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eupraxia Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eupraxia Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eupraxia Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals pink sheet market strength indicators, traders can identify Eupraxia Pharmaceuticals Common entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Risk Indicators
The analysis of Eupraxia Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eupraxia Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eupraxia pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.54 | |||
| Semi Deviation | 3.85 | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.71 | |||
| Downside Variance | 19.28 | |||
| Semi Variance | 14.83 | |||
| Expected Short fall | (4.13) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eupraxia Pink Sheet Analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.